- Home
- TARA vs WHG Comparison
TARA vs WHG Comparison
Compare TARA & WHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARA
- WHG
- Stock Information
- Founded
- TARA N/A
- WHG 1983
- Country
- TARA United States
- WHG United States
- Employees
- TARA N/A
- WHG N/A
- Industry
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- WHG Investment Managers
- Sector
- TARA Health Care
- WHG Finance
- Exchange
- TARA Nasdaq
- WHG Nasdaq
- Market Cap
- TARA 165.5M
- WHG 157.9M
- IPO Year
- TARA N/A
- WHG 2002
- Fundamental
- Price
- TARA $7.59
- WHG $16.14
- Analyst Decision
- TARA Strong Buy
- WHG
- Analyst Count
- TARA 7
- WHG 0
- Target Price
- TARA $20.33
- WHG N/A
- AVG Volume (30 Days)
- TARA 613.6K
- WHG 8.5K
- Earning Date
- TARA 11-10-2025
- WHG 10-30-2025
- Dividend Yield
- TARA N/A
- WHG 3.62%
- EPS Growth
- TARA N/A
- WHG 154.57
- EPS
- TARA N/A
- WHG 0.82
- Revenue
- TARA N/A
- WHG $96,243,000.00
- Revenue This Year
- TARA N/A
- WHG N/A
- Revenue Next Year
- TARA N/A
- WHG N/A
- P/E Ratio
- TARA N/A
- WHG $20.13
- Revenue Growth
- TARA N/A
- WHG 4.20
- 52 Week Low
- TARA $2.28
- WHG $13.49
- 52 Week High
- TARA $10.48
- WHG $18.97
- Technical
- Relative Strength Index (RSI)
- TARA 77.80
- WHG 53.73
- Support Level
- TARA $5.00
- WHG $15.31
- Resistance Level
- TARA $6.85
- WHG $16.93
- Average True Range (ATR)
- TARA 0.55
- WHG 0.58
- MACD
- TARA 0.24
- WHG 0.00
- Stochastic Oscillator
- TARA 99.43
- WHG 75.81
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About WHG Westwood Holdings Group Inc
Westwood Holdings Group Inc manages investment assets and provides services for clients through subsidiaries. It operates its business through the Advisory and Trust segments. Its advisory segment provides investment advisory services to corporate retirement plans, public retirement plans, endowments, foundations, individuals and the Westwood Funds, as well as investment sub-advisory services to mutual funds and its trust segment. The Trust segment offers trust and custodial services to its clients and its advisory segment sponsors common trust funds to institutions and high net-worth individuals. It generates maximum revenue from the Advisory segment. Geographically, it derives a majority of its revenue from the United States.